Compare SCHW & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCHW | BSX |
|---|---|---|
| Founded | 1971 | 1979 |
| Country | United States | United States |
| Employees | 32700 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1B | 137.8B |
| IPO Year | N/A | 2010 |
| Metric | SCHW | BSX |
|---|---|---|
| Price | $93.15 | $69.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 20 |
| Target Price | ★ $114.25 | $108.75 |
| AVG Volume (30 Days) | 9.6M | ★ 11.3M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $12.83 | $12.04 |
| Revenue Next Year | $8.79 | $10.48 |
| P/E Ratio | ★ $20.51 | $35.33 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $65.88 | $67.56 |
| 52 Week High | $107.50 | $109.50 |
| Indicator | SCHW | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 30.45 |
| Support Level | $91.05 | N/A |
| Resistance Level | $97.86 | $76.77 |
| Average True Range (ATR) | 2.23 | 1.87 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 36.81 | 17.55 |
Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.9 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of 2025. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.